The Role of Apolipoprotein E in Alzheimer's Disease

Jungsu Kim, Jacob M. Basak, David M. Holtzman

Research output: Contribution to journalReview article

Abstract

The ε4 allele of apolipoprotein E (APOE) is the major genetic risk factor for Alzheimer's disease (AD). Although there have been numerous studies attempting to elucidate the underlying mechanism for this increased risk, how apoE4 influences AD onset and progression has yet to be proven. However, prevailing evidence suggests that the differential effects of apoE isoforms on Aβ aggregation and clearance play the major role in AD pathogenesis. Other potential mechanisms, such as the differential modulation of neurotoxicity and tau phosphorylation by apoE isoforms as well as its role in synaptic plasticity and neuroinflammation, have not been ruled out. Inconsistent results among studies have made it difficult to define whether the APOE ε4 allele represents a gain of toxic function, a loss of neuroprotective function, or both. Therapeutic strategies based on apoE propose to reduce the toxic effects of apoE4 or to restore the physiological, protective functions of apoE.

Original languageEnglish (US)
Pages (from-to)287-303
Number of pages17
JournalNeuron
Volume63
Issue number3
DOIs
StatePublished - Aug 13 2009
Externally publishedYes

Fingerprint

Apolipoprotein E4
Apolipoproteins E
Alzheimer Disease
Poisons
Protein Isoforms
Alleles
Neuronal Plasticity
Disease Progression
Phosphorylation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

The Role of Apolipoprotein E in Alzheimer's Disease. / Kim, Jungsu; Basak, Jacob M.; Holtzman, David M.

In: Neuron, Vol. 63, No. 3, 13.08.2009, p. 287-303.

Research output: Contribution to journalReview article

Kim, Jungsu ; Basak, Jacob M. ; Holtzman, David M. / The Role of Apolipoprotein E in Alzheimer's Disease. In: Neuron. 2009 ; Vol. 63, No. 3. pp. 287-303.
@article{74af946bbc2f4c03987fe97269aa1950,
title = "The Role of Apolipoprotein E in Alzheimer's Disease",
abstract = "The ε4 allele of apolipoprotein E (APOE) is the major genetic risk factor for Alzheimer's disease (AD). Although there have been numerous studies attempting to elucidate the underlying mechanism for this increased risk, how apoE4 influences AD onset and progression has yet to be proven. However, prevailing evidence suggests that the differential effects of apoE isoforms on Aβ aggregation and clearance play the major role in AD pathogenesis. Other potential mechanisms, such as the differential modulation of neurotoxicity and tau phosphorylation by apoE isoforms as well as its role in synaptic plasticity and neuroinflammation, have not been ruled out. Inconsistent results among studies have made it difficult to define whether the APOE ε4 allele represents a gain of toxic function, a loss of neuroprotective function, or both. Therapeutic strategies based on apoE propose to reduce the toxic effects of apoE4 or to restore the physiological, protective functions of apoE.",
author = "Jungsu Kim and Basak, {Jacob M.} and Holtzman, {David M.}",
year = "2009",
month = "8",
day = "13",
doi = "10.1016/j.neuron.2009.06.026",
language = "English (US)",
volume = "63",
pages = "287--303",
journal = "Neuron",
issn = "0896-6273",
publisher = "Cell Press",
number = "3",

}

TY - JOUR

T1 - The Role of Apolipoprotein E in Alzheimer's Disease

AU - Kim, Jungsu

AU - Basak, Jacob M.

AU - Holtzman, David M.

PY - 2009/8/13

Y1 - 2009/8/13

N2 - The ε4 allele of apolipoprotein E (APOE) is the major genetic risk factor for Alzheimer's disease (AD). Although there have been numerous studies attempting to elucidate the underlying mechanism for this increased risk, how apoE4 influences AD onset and progression has yet to be proven. However, prevailing evidence suggests that the differential effects of apoE isoforms on Aβ aggregation and clearance play the major role in AD pathogenesis. Other potential mechanisms, such as the differential modulation of neurotoxicity and tau phosphorylation by apoE isoforms as well as its role in synaptic plasticity and neuroinflammation, have not been ruled out. Inconsistent results among studies have made it difficult to define whether the APOE ε4 allele represents a gain of toxic function, a loss of neuroprotective function, or both. Therapeutic strategies based on apoE propose to reduce the toxic effects of apoE4 or to restore the physiological, protective functions of apoE.

AB - The ε4 allele of apolipoprotein E (APOE) is the major genetic risk factor for Alzheimer's disease (AD). Although there have been numerous studies attempting to elucidate the underlying mechanism for this increased risk, how apoE4 influences AD onset and progression has yet to be proven. However, prevailing evidence suggests that the differential effects of apoE isoforms on Aβ aggregation and clearance play the major role in AD pathogenesis. Other potential mechanisms, such as the differential modulation of neurotoxicity and tau phosphorylation by apoE isoforms as well as its role in synaptic plasticity and neuroinflammation, have not been ruled out. Inconsistent results among studies have made it difficult to define whether the APOE ε4 allele represents a gain of toxic function, a loss of neuroprotective function, or both. Therapeutic strategies based on apoE propose to reduce the toxic effects of apoE4 or to restore the physiological, protective functions of apoE.

UR - http://www.scopus.com/inward/record.url?scp=68249134074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68249134074&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2009.06.026

DO - 10.1016/j.neuron.2009.06.026

M3 - Review article

C2 - 19679070

AN - SCOPUS:68249134074

VL - 63

SP - 287

EP - 303

JO - Neuron

JF - Neuron

SN - 0896-6273

IS - 3

ER -